Biopsy Devices Market Share, Size, Trends, Forecast and Analysis of Key players 2027
According to the biopsy devices market report by IMARC Group, the market size reached US$ 2.33 Billion in 2021. Looking forward, the market expected to reach a value of US$ 3.43 Billion by 2027, exhibiting a CAGR of 6.69% during 2022-2027.
Year Considered to Estimate the Market Size:
Base Year of the Analysis: 2021
Historical Period: 2016-2021
Forecast Period: 2022-2027
Biopsy devices assist surgeons, cardiologists and other medical practitioners in performing the surgical removal of tissues from any part of the body to examine the presence of a disease. They are also utilized for surgically removing a suspicious nodule or lump with the help of ultrasound, x-ray, computed tomography (CT), or magnetic resonance imaging (MRI). These imaging techniques determine precisely where the needle needs to be placed for performing the biopsy.
COVID-19 Impact Analysis
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/biopsy-devices-market/requestsample
Competitive landscape
The competitive landscape of the market has been examined, with some of the key players being Argon Medical Devices, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Danaher Corporation, Hologic, Inc. and Medtronic PLC.
Global Biopsy Devices Market Trends:
According to the World Health Organization (WHO), cancer is one of the leading causes of death and resulted in around 9.6 million deaths across the globe in 2018. The increasing prevalence of the disease represents one of the significant factors strengthening the biopsy devices market growth. Apart from this, the increasing awareness among individuals about the availability of diagnostic and screening procedures for chronic diseases is positively influencing the demand for integrated technologies, such as stereotactic-guided biopsies.
Furthermore, the development of vacuum-assisted guns and smart biopsy systems are helping in distinguishing healthy cells from tumorous ones. Some of the other factors anticipated to bolster the market growth in the upcoming years are the growing geriatric population, rising healthcare expenditure, increasing initiatives undertaken by governing agencies of various countries and extensive research and development (R&D) activities.
Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=1965&flag=C
The report cover the below key market segments:
Breakup by Procedure Type:
-
- Surgical Biopsy
- Needle Biopsy
Breakup by Product:
-
- Biopsy Guidance Systems
- Needle Based Biopsy Guns
- Biopsy Needles
- Biopsy Forceps
- Others
Breakup by Application:
-
- Breast Biopsy
- Lung Biopsy
- Colorectal Biopsy
- Prostate Biopsy
- Others
Breakup by Guidance Technique:
-
- Ultrasound Guided Biopsy
- Stereotactic Guided Biopsy
- MRI Guided Biopsy
- Others
Breakup by End-User:
-
- Hospitals and Clinics
- Academic and Research Institutes
- Others
By Geography:
-
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
- North America
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
SIIT Courses and Certification
Also Online IT Certification Courses & Online Technical Certificate Programs